MedTrace Logo

Expression of Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Patients

NCT05089110 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-10-26

No results posted yet for this study

Summary

The aim of the study is to assess the expression of TLR 3, 7, and 9 in the population of peripheral blood mononuclear cells (PBMC) and in B lymphocytes (CD19+), T lymphocytes (CD4+ and CD8+) using flow cytometry in relation to the clinical parameters and outcome of COVID 19 patients .

Conditions

  • COVID-19 Respiratory Infection

Interventions

PROCEDURE

blood sample

5 cm blood sample from COVID-19 patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Gamal Agamy, professor · Assiut University

  • Mohammad Adam, professor · Assiut University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-11-01
Completion
2024-11-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05089110 on ClinicalTrials.gov